Codexis Inc (CDXS)
2.66
+0.01
(+0.38%)
USD |
NASDAQ |
Apr 26, 16:00
2.655
0.00 (0.00%)
After-Hours: 20:00
Codexis 1 Year Total Returns (Daily): -32.83% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 26, 2024 | -32.83% |
April 25, 2024 | -34.89% |
April 24, 2024 | -32.85% |
April 23, 2024 | -32.56% |
April 22, 2024 | -33.49% |
April 19, 2024 | -33.25% |
April 18, 2024 | -32.69% |
April 17, 2024 | -36.41% |
April 16, 2024 | -33.41% |
April 15, 2024 | -34.39% |
April 12, 2024 | -30.34% |
April 11, 2024 | -23.77% |
April 10, 2024 | -24.21% |
April 09, 2024 | -20.64% |
April 08, 2024 | -21.13% |
April 05, 2024 | -18.83% |
April 04, 2024 | -19.14% |
April 03, 2024 | -17.94% |
April 02, 2024 | -19.57% |
April 01, 2024 | -15.82% |
March 28, 2024 | -9.82% |
March 27, 2024 | -8.36% |
March 26, 2024 | -11.08% |
March 25, 2024 | -11.08% |
March 22, 2024 | -9.45% |
Date | Value |
---|---|
March 21, 2024 | -13.61% |
March 20, 2024 | -9.59% |
March 19, 2024 | -15.94% |
March 18, 2024 | -16.45% |
March 15, 2024 | -19.95% |
March 14, 2024 | -24.35% |
March 13, 2024 | -19.91% |
March 12, 2024 | -15.78% |
March 11, 2024 | -12.38% |
March 08, 2024 | -23.57% |
March 07, 2024 | -20.43% |
March 06, 2024 | -21.55% |
March 05, 2024 | -23.73% |
March 04, 2024 | -14.71% |
March 01, 2024 | -0.43% |
February 29, 2024 | -3.83% |
February 28, 2024 | -23.06% |
February 27, 2024 | -10.37% |
February 26, 2024 | -32.35% |
February 23, 2024 | -44.81% |
February 22, 2024 | -47.82% |
February 21, 2024 | -47.61% |
February 20, 2024 | -49.56% |
February 16, 2024 | -40.78% |
February 15, 2024 | -43.06% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.50%
Minimum
Dec 27 2022
188.1%
Maximum
Nov 08 2021
-11.14%
Average
-24.21%
Median
Apr 10 2024
1 Year Total Returns (Daily) Benchmarks
Sutro Biopharma Inc | -22.62% |
Avidity Biosciences Inc | 40.48% |
Taysha Gene Therapies Inc | 264.0% |
Janux Therapeutics Inc | 224.4% |
Tango Therapeutics Inc | 127.5% |